Anson Funds Management LP Bristol Myers Squibb CO Transaction History

Anson Funds Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $21.4 Million - $24.1 Million	-360,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $20.8 Million - $23.6 Million	360,700 New	360,700 $249,000
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $1.3 Million - $1.52 Million	-23,700 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $728,480 - $1.06 Million	15,700 Added 196.25%	23,700 $1.32 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $393,680 - $513,520	8,000 New	8,000 $514,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

Stay updated on Anson Funds Management LP with notifications on news.